Reliq Health Technologies (TSXV:RHT.H) ROCE %: -6.26% (As of Sep. 2022)


TSXV:RHT.H Reliq Health Technologies Inc TSXV:RHT.H
10 GF Score
Price C$0.22
View Full Analysis

What is Reliq Health Technologies ROCE %?

Reliq Health Technologies TSXV:RHT.H 10 ROCE % is -6.26% as of Sep. 2022. GuruFocus rates TSXV:RHT.H with a GF Score™ of 10/100.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Reliq Health Technologies's annualized ROCE % for the quarter that ended in Sep. 2022 was -6.26%.

Reliq Health Technologies  (TSXV:RHT.H) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Reliq Health Technologies ROCE % Related Terms

Reliq Health Technologies ROCE % Historical Data

* Premium members only.

The historical data trend for Reliq Health Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Reliq Health Technologies ROCE % Chart

Reliq Health Technologies Annual Data
Trend Dec13 Dec14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -213.55 -177.58 -540.91 -935.35 -209.18

Reliq Health Technologies Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -577.32 -159.67 -48.28 -57.62 -6.26
TSXV:RHT.H
10GF Score
Reliq Health Technologies Inc TSXV:RHT.H
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Reliq Health Technologies ROCE % Calculation

Reliq Health Technologies's annualized ROCE % for the fiscal year that ended in Jun. 2022 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2022 )  (A: Jun. 2021 )(A: Jun. 2022 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2022 )  (A: Jun. 2021 )(A: Jun. 2022 )
=-8.136/( ( (3.462 - 2.238) + (10.267 - 3.712) )/ 2 )
=-8.136/( (1.224+6.555)/ 2 )
=-8.136/3.8895
=-209.18 %

Reliq Health Technologies's ROCE % of for the quarter that ended in Sep. 2022 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2022 )  (Q: Jun. 2022 )(Q: Sep. 2022 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2022 )  (Q: Jun. 2022 )(Q: Sep. 2022 )
=-0.468/( ( (10.267 - 3.712) + (14.247 - 5.845) )/ 2 )
=-0.468/( ( 6.555 + 8.402 )/ 2 )
=-0.468/7.4785
=-6.26 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2022) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -6.26% mean?
Reliq Health Technologies (TSXV:RHT.H) has a ROCE % of -6.26% as of Sep. 2022.
Is Reliq Health Technologies' ROCE % too high?
Reliq Health Technologies' current ROCE % is -6.26%. Overall, Reliq Health Technologies has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Reliq Health Technologies' ROCE % compare to VEEV and GEHC?
Reliq Health Technologies' ROCE % of -6.26% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Reliq Health Technologies's current ROCE % is -6.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Reliq Health Technologies stock overvalued right now?
Reliq Health Technologies (TSXV:RHT.H) has a current ROCE % of -6.26%. The current ROCE % is -6.26%. Reliq Health Technologies' overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Reliq Health Technologies (TSXV:RHT.H), the current ROCE % is -6.26% as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Reliq Health Technologies Business Description

Address 175 Longwood Rd S., Suite 406A, Hamilton, ON, CAN, L8P 0A1
Reliq Health Technologies Inc specializes in developing Software-as-a-Service (SaaS) solutions for remote patient monitoring, telemedicine, and care collaboration. The company's IUGO health technology platform is a hardware and software solution that allows complex patients to receive high-quality care in the home, improving health outcomes, enhancing the quality of life for patients and families and reducing the cost of care delivery.
10GF Score

Get the complete analysis for TSXV:RHT.H

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.22
Price